Physician profile
Sumit Agarwal
NPI 1306262035
$1,302.43
in general payments reported to CMS, 2019-2025
16 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $58.32 · 2023: $44.23 · 2024: $318 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $355.71 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Allergan, INC. | $151.49 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $140.14 | 2019 | |
| Novo Nordisk INC | $118.47 | 2023-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $103.81 | 2019-2020 | |
| Pfizer INC. | $101.15 | 2024-2025 | |
| Exact Sciences Corporation | $66.63 | 2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $58.73 | 2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.90 | 2019 | |
| Inspire Medical Systems, INC. | $32.68 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $31.37 | 2024 | Nexletol |
| Lilly USA, LLC | $29.87 | 2025 | Kisunla |
| Axsome Therapeutics, INC. | $26.27 | 2023-2024 | Sunosi |
| Krystal Biotech INC | $22.25 | 2025 | Vyjuvek |
| Melinta Therapeutics, LLC | $14.26 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.